| 15th Oct 2026 7:00 am |
RNS-R |
Patents for concentrated ultra-rapid insulins |
| 13th Oct 2026 10:39 am |
RNS |
Holding(s) in Company |
| 13th Oct 2026 10:38 am |
RNS |
Holding(s) in Company |
| 8th Oct 2026 12:56 pm |
RNS-R |
Half Year Results Investor Presentation |
| 8th Oct 2026 11:10 am |
RNS |
Holding(s) in Company |
| 7th Oct 2026 4:00 pm |
RNS |
Result of Retail Offer |
| 7th Oct 2026 2:35 pm |
RNS |
Holding(s) in Company |
| 30th Sep 2026 3:00 pm |
RNS |
Retail Offer to raise up to £130,000 |
| 30th Sep 2026 2:58 pm |
RNS |
Results of Placing |
| 30th Sep 2026 1:29 pm |
RNS |
Close of Accelerated Bookbuild to New Orders |
| 30th Sep 2026 7:01 am |
RNS |
Proposed Fundraising to raise up to £5.13 million |
| 30th Sep 2026 7:00 am |
RNS |
Interim results for the six months to 30 June 2026 |
| 13th Aug 2026 7:00 am |
RNS-R |
AT278 data published in peer-reviewed journal |
| 10th Aug 2026 11:32 am |
RNS |
Holding(s) in Company |
| 28th May 2026 2:00 pm |
RNS |
Result of AGM |
| 21st May 2026 1:00 pm |
RNS |
Grant of options and PDMR dealing |
| 18th May 2026 7:00 am |
RNS-R |
Upcoming conference attendance |
| 28th Apr 2026 4:28 pm |
RNS |
Posting of Annual Report and Notice of AGMm |
| 13th Apr 2026 7:00 am |
RNS |
Final Results |
| 30th Mar 2026 7:00 am |
RNS |
Notice of FY25 Results |
| 26th Mar 2026 7:00 am |
RNS |
Ligand Pharmaceuticals Milestone Payment |
| 9th Mar 2026 7:00 am |
RNS-R |
Arecor to present at Oppenheimer conference |
| 9th Feb 2026 7:00 am |
RNS |
2025 Business Update |
| 6th Jan 2026 2:01 pm |
RNS |
Fireside Panel Discussion on Diabetes sector |
| 9th Dec 2025 7:00 am |
RNS |
Arecor and Sequel Med Tech to host fireside panel |
| 17th Nov 2025 11:37 am |
RNS |
Holding(s) in Company |
| 11th Nov 2025 9:50 am |
RNS |
Holding(s) in Company |
| 4th Nov 2025 7:00 am |
RNS |
Enhanced IP Coverage: AT278 & Oral Peptide Program |
| 29th Sep 2025 7:00 am |
RNS |
Directorate Changes |
| 25th Sep 2025 7:00 am |
RNS |
Interim results for the six months to 30 June 2025 |
| 25th Sep 2025 7:00 am |
RNS |
Co-Development Agreement & Monetisation Deal |
| 24th Sep 2025 9:30 am |
RNS |
Notice of Interim Results |
| 4th Sep 2025 7:00 am |
RNS |
Positive FDA Feedback on Phase 2 Study Design |
| 28th Aug 2025 12:00 pm |
RNS |
Holding(s) in Company |
| 8th Aug 2025 7:00 am |
RNS |
Change of Auditor |
| 14th Jul 2025 7:00 am |
RNS-R |
Arecor Establishes New Scientific Advisory Board |
| 4th Jun 2025 7:00 am |
RNS |
Grant of Options and PDMR Dealing |
| 2nd Jun 2025 1:32 pm |
RNS |
Result of AGM |
| 2nd Jun 2025 7:00 am |
RNS |
Non-Executive Director Board Change |
| 21st May 2025 7:00 am |
RNS |
Director/PDMR Dealing |
